Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Daniela Tapia‐Trejo"'
Autor:
Maribel Soto-Nava, Vanessa Dávila-Conn, Juan P. Venancio-Rocha, Pedro García-Esparza, Daniela Tapia-Trejo, Ramón Hernández-Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila-Ríos
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-12 (2023)
Abstract Objective To assess SARS-CoV-2 antibody prevalence and titers in people living with HIV (PLWHIV) on antiretroviral treatment (ART) enrolled at a tertiary reference hospital in Mexico. Methods Two plasma aliquots per person, used for HIV vira
Externí odkaz:
https://doaj.org/article/38afcb6c5ccf43e3acb183a2432f568e
Autor:
Humberto Valenzuela-Ponce, Candy Carbajal, Maribel Soto-Nava, Daniela Tapia-Trejo, Claudia García-Morales, Wendy Murillo, Ivette Lorenzana, Gustavo Reyes-Terán, Santiago Ávila-Ríos
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT Human leukocyte antigen (HLA) polymorphisms represent the strongest genetic modifier of HIV disease progression. Diverse HLA distributions can lead to distinct HIV control landscapes at the population level. We aimed to describe HLA allele a
Externí odkaz:
https://doaj.org/article/69a6a47656b6468284b1988439b7188e
Autor:
Victor Alberto Hernández-Hernández, Anjarath Lorena Higuera-Iglesias, Gabriel Palma-Cortes, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Rubén Roberto González-Fernández, Luis Ángel Pérez-Moreno, Joaquín Alejandro Zuñiga-Ramos, Cristóbal Guadarrama-Pérez, José Luis Sandoval-Gutiérrez, Carlos Cabello-Gutiérrez, Dr
Publikováno v:
International Journal of Infectious Diseases, Vol 125, Iss , Pp 114-119 (2022)
Objectives: We evaluated the VE and the mutations of the viruses present in the Mexican population at the beginning of 2018. Methods: We diagnosed influenza in outpatients with a high-performance Rapid Influenza Diagnostic Test (RIDT) qRT–PCR. Desc
Externí odkaz:
https://doaj.org/article/5bafb4f8498f43cfb0c714a3da9d5004
Autor:
Eva Bednarski, Perla M. Del Rio Estrada, Justin DaSilva, Celia Boukadida, Fengwen Zhang, Yara A. Luna-Villalobos, Ximena Rodríguez-Rangel, Elvira Pitén-Isidro, Edgar Luna-García, Dafne Díaz Rivera, Dulce M. López-Sánchez, Daniela Tapia-Trejo, Maribel Soto-Nava, Myriam Astorga-Castañeda, José O. Martínez-Moreno, Guadalupe S. Urbina-Granados, José A. Jiménez-Jacinto, Francisco J. Serna Alvarado, Yerania E. Enriquez-López, Oliva López-Arellano, Gustavo Reyes-Teran, Paul D. Bieniasz, Santiago Avila-Rios, Theodora Hatziioannou
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT Global population immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is accumulating through heterogeneous combinations of infection and vaccination. Vaccine distribution in low- and middle-income countries has been var
Externí odkaz:
https://doaj.org/article/f3466aec2fa541f5b3b52f21336f628f
Autor:
Rosa Flieller, Susana Cabrera, Dora Ruchansky, Amalia Girón-Callejas, María Brasesco, Daniel Pérez, Héctor Chiparelli, Claudia García-Morales, Daniela Tapia-Trejo, Jessica Monreal-Flores, Giovanni Ravasi, Michael R. Jordan, Santiago Ávila-Ríos
Publikováno v:
Viruses, Vol 15, Iss 2, p 490 (2023)
The first nationally representative cross-sectional HIV drug resistance (HIVDR) survey was conducted in Uruguay in 2018–2019 among adults diagnosed with HIV and initiating or reinitiating antiretroviral therapy (ART). Protease, reverse transcriptas
Externí odkaz:
https://doaj.org/article/342fda1b415949849eac86e9c3bd3e8c
Autor:
Vanessa Dávila-Conn, Maribel Soto-Nava, Yanink N. Caro-Vega, Héctor E. Paz-Juárez, Pedro García-Esparza, Daniela Tapia-Trejo, Marissa Pérez-García, Pablo F. Belaunzarán-Zamudio, Gustavo Reyes-Terán, Juan G. Sierra-Madero, Arturo Galindo-Fraga, Santiago Ávila-Ríos
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Introduction We performed a longitudinal SARS-CoV-2 seroepidemiological study in healthcare personnel of the two largest tertiary COVID-19 referral hospitals in Mexico City. Methods All healthcare personnel, including staff physicians, physicians in
Externí odkaz:
https://doaj.org/article/268f05f9969e4378be208e02fa7141c1
Autor:
Ricardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Fidencio Mejía-Nepomuceno, Emma García, Manuel Castillejos-López, Anjarath Lorena Higuera-Iglesias, Arnoldo Aquino-Gálvez, Ireri Thirion-Romero, Rogelio Pérez-Padilla, José Leopoldo Aguilar-Faisal, Joel Armando Vázquez-Pérez
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2063 (2022)
The host immune response to SARS-CoV-2 appears to play a critical role in disease pathogenesis and clinical manifestations in severe COVID-19 cases. Until now, the importance of developing a neutralizing antibody response in the acute phase and its r
Externí odkaz:
https://doaj.org/article/7a15d8ea2dfd4f10b1031596ab335da1
Autor:
Claudia García-Morales, Daniela Tapia-Trejo, Margarita Matías-Florentino, Verónica Sonia Quiroz-Morales, Vanessa Dávila-Conn, Ángeles Beristain-Barreda, Miroslava Cárdenas-Sandoval, Manuel Becerril-Rodríguez, Patricia Iracheta-Hernández, Israel Macías-González, Rebecca García-Mendiola, Alejandro Guzmán-Carmona, Eduardo Zarza-Sánchez, Raúl Adrián Cruz, Andrea González-Rodríguez, Gustavo Reyes-Terán, Santiago Ávila-Ríos
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1587 (2021)
In response to increasing pretreatment drug resistance (PDR), Mexico changed its national antiretroviral treatment (ART) policy, recommending and procuring second-generation integrase strand-transfer inhibitor (INSTI)-based regimens as preferred firs
Externí odkaz:
https://doaj.org/article/f615ace142d24be98a31847b2642c1d6
Autor:
Yaxelis Mendoza, Claudia García-Morales, Gonzalo Bello, Daniela Garrido-Rodríguez, Daniela Tapia-Trejo, Juan Miguel Pascale, Amalia Carolina Girón-Callejas, Ricardo Mendizábal-Burastero, Ingrid Yessenia Escobar-Urias, Blanca Leticia García-González, Jessenia Sabrina Navas-Castillo, María Cristina Quintana-Galindo, Rodolfo Pinzón-Meza, Carlos Rodolfo Mejía-Villatoro, Santiago Avila-Ríos, Gustavo Reyes-Terán
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203916 (2018)
Different explanations exist on how HIV-1 subtype B spread in Central America, but the role of Guatemala, the Central American country with the highest number of people living with the virus, in this scenario is unknown. We investigated the evolution
Externí odkaz:
https://doaj.org/article/8538dc5eaa4e4f2daaafd512f773a7bc
Autor:
Santiago Avila-Ríos, Claudia García-Morales, Margarita Matías-Florentino, Daniela Tapia-Trejo, Bismarck F Hernández-Álvarez, Sumaya E Moreira-López, Carlos J Quant-Durán, Guillermo Porras-Cortés, Gustavo Reyes-Terán
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164156 (2016)
BACKGROUND:Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR sur
Externí odkaz:
https://doaj.org/article/ef16b09bade14d168235467a6c3441e6